Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
It puts retatrutide on a different efficacy plateau than the GLP-1 and dual-incretin agonists that have driven the obesity drug market for the last three years
Compounds like semaglutide activate the single GLP-1 receptor
Here's a comprehensive guide to help you make informed decisions
It is undergoing rigorous Phase 3 testing and has not yet received final approval from the FDA or MHRA for general prescription use
Certain medications or procedures might be covered by your insurance, so we recommend checking with your insurance to see if you qualify
US$ 25.64
US$ 22.20
US$ 23.93
US$ 27.64
US$ 23.37
US$ 22.09
